ImmunoPrecise Antibodies

$10.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.31 (-10.95%) As of 5:17 PM UTC today

Why Robinhood?

You can buy or sell IPA and other stocks, options, and ETFs commission-free!

About IPA

ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada. The listed name for IPA is ImmunoPrecise Antibodies Ltd. Common Stock.

CEO
Jennifer Bath
Employees
—
Headquarters
Victoria, British Columbia
Founded
1983
Market Cap
203.38M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
163.32K
High Today
$11.75
Low Today
$10.16
Open Price
$11.75
Volume
97.77K
52 Week High
$33.34
52 Week Low
$2.09

You May Also Like

FSRV
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure